Heart Failure with preserved Ejection Fraction (HFpEF)
Conditions
Interventions
Diagnostic measurements performed as part of routine clinical care
Sponsors
WCN
Eligibility
Inclusion criteria
Inclusion criteria: Age 18 years or more;Referred to the cardiology clinic of the participating center for HF-like symptoms - as stated in the ESC 2016 Guidelines;H2FpEF score of 3 or more
Exclusion criteria
Exclusion criteria: Known with a history of HF (despite LVEF);Known with a history of severe valvular or congenital heart disease;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the number of patients diagnosed with HFpEF at 6 months and 12 months follow-up, compared to the initial H2FPEF score (5 or less versus 6 or more). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are: availability of echocardiographic parameters in clinical reports; Characterization and overlap/discrepancy among H2FPEF, HFA-PEFF, and HFpEF-ABA likelihood scores; Guideline-directed optimal medical therapy use at 6 and 12 months, stratified by diagnosis and likelihood scores; HF events and mortality, stratified by diagnosis and likelihood scores; (Incremental) Diagnostic and/or prognostic value of clinical parameters, developing or improving existing models. | — |
Countries
Netherlands
Contacts
Public ContactA. Schut
WCN
Outcome results
None listed